Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
NCT00161772
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Tick-borne Encephalitis
Interventions
BIOLOGICAL:
Tick-borne Encephalitis Vaccine
Sponsor
Pfizer